Clinical trials in Pleven – page 13

300 clinical trials in Pleven, Bulgaria across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

Pleven at a glance

300

clinical trials

Research sites2

Quick filters

300 trials in Pleven

Open in trial search

Chronic obstructive pulmonary disease

Not recruiting

Study on the Effectiveness and Safety of CHF6001 DPI with Roflumilast for Patients with Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis

Investigational

Study on the Effectiveness and Safety of CHF6001 DPI with Roflumilast for Patients with Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis

Investigational

Bulgaria

Participants:18–64 years · 65+ years
Substances:Roflumilast
Sponsor:Chiesi Farmaceutici S.p.A.

Contact Research Centre

Chronic spontaneous urticaria

Not recruiting

Study Comparing BP11 and Omalizumab for Patients with Chronic Spontaneous Urticaria Resistant to H1 Antihistamines

Registered drug

Study Comparing BP11 and Omalizumab for Patients with Chronic Spontaneous Urticaria Resistant to H1 Antihistamines

Registered drug

Bulgaria

Participants:18–64 years · 65+ years
Substances:Omalizumab
Sponsor:Curateq Biologics Private Limited

Contact Research Centre

Dermatitis atopic

Not recruiting

Study on the Long-Term Safety and Efficacy of Nemolizumab for Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis

InvestigationalNo placebo

Study on the Long-Term Safety and Efficacy of Nemolizumab for Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis

InvestigationalNo placebo

Bulgaria

Participants:0–17 years · 18–64 years · 65+ years
Substances:Nemolizumab
Sponsor:Galderma S.A.

Contact Research Centre

Hypertriglyceridaemia

Not recruiting

Study of Plozasiran for Adults with Severe Hypertriglyceridemia

Investigational

Study of Plozasiran for Adults with Severe Hypertriglyceridemia

Investigational

Bulgaria

Participants:18–64 years · 65+ years
Substances:Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues
Sponsor:Arrowhead Pharmaceuticals Inc.

Contact Research Centre

Hypertriglyceridaemia

Not recruiting

Study to Evaluate Plozasiran for Adults with High Triglycerides

Investigational

Study to Evaluate Plozasiran for Adults with High Triglycerides

Investigational

Bulgaria

Participants:18–64 years · 65+ years
Substances:Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues
Sponsor:Arrowhead Pharmaceuticals Inc.

Contact Research Centre

Chronic spontaneous urticaria

Not recruiting

Study on Barzolvolimab for Patients with Chronic Spontaneous Urticaria Unresponsive to H1 Antihistamines

Registered drug

Study on Barzolvolimab for Patients with Chronic Spontaneous Urticaria Unresponsive to H1 Antihistamines

Registered drug

Bulgaria

Participants:18–64 years · 65+ years
Substances:Barzolvolimab
Sponsor:Celldex Therapeutics Inc.

Contact Research Centre

Type 2 diabetes mellitus

Not recruiting

Study on the Effects of Semaglutide on Diabetic Eye Disease in People with Type 2 Diabetes

Registered drug

Study on the Effects of Semaglutide on Diabetic Eye Disease in People with Type 2 Diabetes

Registered drug

Bulgaria

Participants:18–64 years · 65+ years
Substances:Semaglutide
Sponsor:Novo Nordisk A/S

Contact Research Centre

Psoriatic arthropathy

Not recruiting

Study of Risankizumab vs. Placebo for Patients with Active Psoriatic Arthritis and Inadequate Response to DMARD Therapy

Investigational

Study of Risankizumab vs. Placebo for Patients with Active Psoriatic Arthritis and Inadequate Response to DMARD Therapy

Investigational

Bulgaria

Participants:18–64 years · 65+ years
Substances:Risankizumab
Sponsor:AbbVie Deutschland GmbH & Co. KG

Contact Research Centre

Dermatitis atopic

Not recruiting

Study on the Effects of GSK1070806 Injection in Adults with Moderate to Severe Atopic Dermatitis

Investigational

Study on the Effects of GSK1070806 Injection in Adults with Moderate to Severe Atopic Dermatitis

Investigational

Bulgaria

Participants:18–64 years · 65+ years
Substances:Humanised IgG1 kappa monoclonal antibody against interleukin 18
Sponsor:Glaxosmithkline Research & Development Limited

Contact Research Centre

Chronic kidney disease

Not recruiting

Study on the Effects of Zibotentan and Dapagliflozin in Patients with Chronic Kidney Disease and High Protein Levels

Registered drugNo placebo

Study on the Effects of Zibotentan and Dapagliflozin in Patients with Chronic Kidney Disease and High Protein Levels

Registered drugNo placebo

Bulgaria

Participants:18–64 years · 65+ years
Substances:Dapagliflozin
Sponsor:AstraZeneca AB

Contact Research Centre

Vitiligo

Not recruiting

Study of ritlecitinib (50 mg and 100 mg daily) compared to placebo in adults with nonsegmental vitiligo

Registered drug

Study of ritlecitinib (50 mg and 100 mg daily) compared to placebo in adults with nonsegmental vitiligo

Registered drug

Bulgaria

Participants:18–64 years · 65+ years
Substances:Dexamethasone
Sponsor:Pfizer Inc.

Contact Research Centre

Chronic obstructive pulmonary disease

Not recruiting

Study on the Effects of Budesonide, Glycopyrronium, and Formoterol in Patients Aged 40-80 with Chronic Obstructive Pulmonary Disease (COPD)

Registered drug

Study on the Effects of Budesonide, Glycopyrronium, and Formoterol in Patients Aged 40-80 with Chronic Obstructive Pulmonary Disease (COPD)

Registered drug

Bulgaria

Participants:18–64 years · 65+ years
Substances:Budesonide
Sponsor:AstraZeneca AB

Contact Research Centre

Other cities in Bulgaria

The busiest research cities in the country

All 53 cities in Bulgaria

Clinical research in Pleven

What the registry says about research in the country

01 Respiratory Health

Innovative research focusing on viral respiratory infections, including studies of vaccines against RSV, human metapneumovirus, and influenza in older adults. Clinical trials aim to enhance protection against severe respiratory diseases.

RSV and hMPV Prevention
Influenza Vaccine Development
Viral Lung Infection Treatment

Emphasis on vaccine efficacy and immune response in vulnerable populations.

02 Dermatological Conditions

Comprehensive studies addressing various skin conditions, with particular focus on psoriasis and hidradenitis suppurativa. Research includes both systemic and targeted therapies.

Plaque Psoriasis Management
Hidradenitis Suppurativa Treatment
Genital Psoriasis Therapy

Innovative approaches in chronic skin condition management.

03 Cardiovascular Research

Advanced studies in cardiovascular disease prevention and treatment, including investigations into heart failure prevention and lipid management strategies.

Heart Failure Prevention
Lipoprotein Management
Cardiovascular Risk Reduction

Focus on preventive strategies and innovative therapeutic approaches.

04 Autoimmune Disorders

Investigations into various autoimmune conditions, including multiple sclerosis and Sjögren's disease, exploring new therapeutic options and treatment approaches.

Multiple Sclerosis Treatment
Sjögren's Disease Management
Inflammatory Disease Therapy

Emphasis on improving quality of life for patients with chronic conditions.

Back to Bulgaria All countries

Clinical trials in Pleven – page 13

300 trials in Pleven

Chronic obstructive pulmonary disease

Study on the Effectiveness and Safety of CHF6001 DPI with Roflumilast for Patients with Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis

Chronic spontaneous urticaria

Study Comparing BP11 and Omalizumab for Patients with Chronic Spontaneous Urticaria Resistant to H1 Antihistamines

Dermatitis atopic

Study on the Long-Term Safety and Efficacy of Nemolizumab for Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis

Hypertriglyceridaemia

Study of Plozasiran for Adults with Severe Hypertriglyceridemia

Hypertriglyceridaemia

Study to Evaluate Plozasiran for Adults with High Triglycerides

Chronic spontaneous urticaria

Study on Barzolvolimab for Patients with Chronic Spontaneous Urticaria Unresponsive to H1 Antihistamines

Type 2 diabetes mellitus

Study on the Effects of Semaglutide on Diabetic Eye Disease in People with Type 2 Diabetes

Psoriatic arthropathy

Study of Risankizumab vs. Placebo for Patients with Active Psoriatic Arthritis and Inadequate Response to DMARD Therapy

Dermatitis atopic

Study on the Effects of GSK1070806 Injection in Adults with Moderate to Severe Atopic Dermatitis

Chronic kidney disease

Study on the Effects of Zibotentan and Dapagliflozin in Patients with Chronic Kidney Disease and High Protein Levels

Vitiligo

Study of ritlecitinib (50 mg and 100 mg daily) compared to placebo in adults with nonsegmental vitiligo

Chronic obstructive pulmonary disease

Study on the Effects of Budesonide, Glycopyrronium, and Formoterol in Patients Aged 40-80 with Chronic Obstructive Pulmonary Disease (COPD)

Filter the trials

Other cities in Bulgaria

Clinical research in Pleven

Prefer not to search? Our Concierge searches the trials for you.

Clinical trials in Pleven – page 13

300 trials in Pleven

Other cities in Bulgaria

Related

Clinical research in Pleven

Prefer not to search? Our Concierge searches the trials for you.